* Predictive Oncology Inc POAI.OQ reported a quarterly
adjusted loss of 8 cents per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 5 cents per share.
* Revenue was $314.00 thousand; analysts expected $1.20
million.
* Predictive Oncology Inc's reported EPS for the quarter was a
loss of 8 cents.
* The mean earnings estimate of analysts had risen by
about 16.7% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Predictive Oncology Inc shares had fallen by 13.5% this
quarter and gained 57.0% so far this year.
* The company reported a quarterly loss of $5.44 million.
* Wall Street's median 12-month price target for Predictive
Oncology Inc is $5.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated November 15 at 10:01 p.m.
All figures in US dollars unless otherwise stated